Both in Biotechnology
Neumora Therapeutics vs Voyager Therapeutics
Over the past year NMRA returned −80.3% and VYGR returned −59.2%; their daily moves had a correlation of 0.19.
NMRA −80.3% VYGR −59.2%Growth of $1, one year, split-adjusted
| Metric | NMRA | VYGR |
|---|---|---|
| Price | $0.5932 | $1.88 |
| Market cap | $111.5M | $115.5M |
| Today | +3.91% | +2.46% |
| 1 month | +25.9% | −23.8% |
| 6 months | −74.5% | −55.0% |
| Year to date | −66.9% | −52.3% |
| 1 year | −80.3% | −59.2% |
| Revenue growth (YoY) | — | −39.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −773.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.4× |
| Net cash | $63.9M | $116.3M |
| Dividend yield | — | — |
| Volatility (60d) | 126.1% | 61.2% |
| Short % of float | 6.9% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).